Evidence map›Paper›PMID 29312621›Full record

ArticleOncotarget2017

Elevated red blood cell distribution width predicts poor prognosis in hilar cholangiocarcinoma.

Bei Li, Zhen You, Xian-Ze Xiong, Yong Zhou, Si-Jia Wu, Rong-Xing Zhou, Jiong Lu, Nan-Sheng Cheng

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bei LiDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.
Zhen YouDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.
Xian-Ze XiongDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.
Yong ZhouDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.
Si-Jia WuDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.
Rong-Xing ZhouDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.
Jiong LuDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.
Nan-Sheng ChengDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.
Sichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough the red blood cell distribution width (RDW) has been reported as a reliable predictor of prognosis in several types of cancer, the prognostic value of RDW in hilar cholangiocarcinoma (HC) has not been studied.

methodsA retrospective analysis of 292 consecutively recruited HC patients undergoing radical resection was conducted. The optimal cutoff value of RDW was determined by the receiver operating characteristic curve (ROC). Survival analysis by the Kaplan-Meier method, the difference between the clinico-pathologic variables and survival were evaluated by log-rank analysis. Multivariate analysis identified independent prognostic risk factors of overall survival (OS).

resultsROC analysis suggested that the optimal cutoff value for the RDW was 14.95. Linear correlation analysis revealed that RDW is associated with white blood cell count (P = 0.007), neutrophil-to-lymphocyte ratio (P = 0.02), and hemoglobin (P < 0.001), albumin (P < 0.001). In a multivariate analysis, the RDW was an independent prognostic factor for OS (HR = 1.755, 95% CI 1.311-2.349, P < 0.001).

conclusionsElevated RDW may be regarded as an indicator of systemic inflammatory response which might facilitate HC growth and metastasis. Current evidence suggests that RDW may have clinical significance in predicting OS after surgery in HC patients.

Indexed as

hilar cholangiocarcinomaprognosisred blood cell distribution widthsystemic inflammatory response

Identifiers

PMID29312621
PMCPMC5752534
OpenAlexW2770245462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.